We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+0.36%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$15.2B
AUM Growth
+$366M
Cap. Flow
+$107M
Cap. Flow %
0.7%
Top 10 Hldgs %
31.7%
Holding
1,371
New
97
Increased
870
Reduced
195
Closed
30

Top Buys

Rank Stock Value
1
INVH icon
Invitation Homes
INVH
+$175M
2
WELL icon
Welltower
WELL
+$148M
3
CUZ icon
Cousins Properties
CUZ
+$121M
4
DLR icon
Digital Realty Trust
DLR
+$103M
5
VICI icon
VICI Properties
VICI
+$96.6M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$266M
2
SUI icon
Sun Communities
SUI
+$169M
3
EXR icon
Extra Space Storage
EXR
+$143M
4
AMT icon
American Tower
AMT
+$103M
5
KRC icon
Kilroy Realty
KRC
+$102M

Sector Composition

Rank Sector Weight
1 Real Estate 55.88%
2 Technology 9.18%
3 Communication Services 4.61%
4 Consumer Discretionary 4.25%
5 Financials 3.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNS icon
1101
Scotiabank
BNS
$108B
$12K ﹤0.01%
190
+60
+46% +$3.75K
KRTX
1102
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$12K ﹤0.01%
101
+47
+87% +$5.43K
ARNA
1103
DELISTED
Arena Pharmaceuticals Inc
ARNA
$12K ﹤0.01%
209
+90
+76% +$5.32K
EDU icon
1104
New Oriental
EDU
$8.08B
$11K ﹤0.01%
520
-7,188
-93% -$228K
GEO icon
1105
PUT
The GEO Group
GEO
$4.11B
$11K ﹤0.01%
769
– –
INSM icon
1106
Insmed
INSM
$22.6B
$11K ﹤0.01%
395
+191
+94% +$5.01K
NKTR icon
1107
Nektar Therapeutics
NKTR
$2.39B
$11K ﹤0.01%
42
+18
+75% +$4.33K
PRTA icon
1108
Prothena Corp
PRTA
$448M
$11K ﹤0.01%
154
+66
+75% +$4.1K
SWTX
1109
DELISTED
SpringWorks Therapeutics
SWTX
$11K ﹤0.01%
168
+76
+83% +$5.86K
VCYT icon
1110
Veracyte
VCYT
$4.44B
$11K ﹤0.01%
243
+110
+83% +$4.8K
RETA
1111
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$11K ﹤0.01%
108
+46
+74% +$5.39K
TPTX
1112
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$11K ﹤0.01%
169
+74
+78% +$5.27K
NFH
1113
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
$11K ﹤0.01%
+1,013
New +$11.3K
ALXO icon
1114
ALX Oncology
ALXO
$268M
$10K ﹤0.01%
138
+59
+75% +$3.93K
APLS
1115
DELISTED
Apellis Pharmaceuticals
APLS
$10K ﹤0.01%
298
+139
+87% +$7.81K
AUPH icon
1116
Aurinia Pharmaceuticals
AUPH
$1.92B
$10K ﹤0.01%
440
+202
+85% +$3.21K
CYTK icon
1117
Cytokinetics
CYTK
$10.8B
$10K ﹤0.01%
286
+153
+115% +$4.5K
EDIT icon
1118
Editas Medicine
EDIT
$402M
$10K ﹤0.01%
234
+101
+76% +$5.53K
NBP
1119
NovaBridge Biosciences American Depositary Shares
NBP
$202M
$10K ﹤0.01%
144
+81
+129% +$5.86K
RLAY icon
1120
Relay Therapeutics
RLAY
$3.99B
$10K ﹤0.01%
317
+148
+88% +$4.98K
ZNTL icon
1121
Zentalis Pharmaceuticals
ZNTL
$329M
$10K ﹤0.01%
154
+78
+103% +$4.5K
ITCI
1122
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$10K ﹤0.01%
279
+128
+85% +$4.45K
ACAD icon
1123
Acadia Pharmaceuticals
ACAD
$4.45B
$9K ﹤0.01%
550
+233
+74% +$4.49K
AGIO icon
1124
Agios Pharmaceuticals
AGIO
$2.14B
$9K ﹤0.01%
202
+80
+66% +$3.87K
BCRX icon
1125
BioCryst Pharmaceuticals
BCRX
$2.48B
$9K ﹤0.01%
613
+281
+85% +$4.43K
43 44
45
46 47

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2021 Portfolio in Review

As of Q3 2021, Daiwa Securities Group held 1,371 positions worth $15.2B, up 2.5% from $14.8B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa Securities Group's Q3 2021 filing shows 97 new, 870 increased, 195 reduced and 30 closed positions. Its largest new stake was Global X Cloud Computing ETF: 500,000 shares worth $14.6M. The largest sale was Equinix, an estimated $266M.

By sector, the portfolio is most concentrated in Real Estate at 56% of assets, down from 59% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q3 2021 buy was Global X Cloud Computing ETF: 500,000 shares worth $14.6M.
  • Daiwa Securities Group added most to Invitation Homes in Q3 2021, an estimated $175M increase.
  • Daiwa Securities Group's biggest Q3 2021 reduction was Equinix, cutting an estimated $266M.
  • Daiwa Securities Group fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.09M.
  • Daiwa Securities Group's ten largest holdings make up 32% of its $15.2B portfolio in Q3 2021.
  • Daiwa Securities Group opened 97 new positions and closed 30 in Q3 2021.
  • Daiwa Securities Group's portfolio value rose 2.5% quarter-over-quarter to $15.2B.

Based on Daiwa Securities Group's 13F filing for Q3 2021, filed 5 Nov 2021.